Lyell Immunopharma, Inc. (LYEL)
25.66
+0.28
(+1.10%)
USD |
NASDAQ |
Feb 13, 09:54
Lyell Immunopharma Free Cash Flow : -165.54M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insmed, Inc. | -906.14M |
| Nektar Therapeutics | -190.35M |
| GT Biopharma, Inc. | -11.36M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.58M |
| Cash from Investing (Quarterly) | 3.349M |
| Cash from Financing (Quarterly) | 50.00M |
| Free Cash Flow Per Share (Quarterly) | -1.568 |
| Free Cash Flow to Equity (Quarterly) | -35.12M |
| Free Cash Flow to Firm (Quarterly) | -28.64M |
| Free Cash Flow Yield | -4.34% |